News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No news articles published in the past hour.
  • No market-moving macro releases or central bank statements reported.
  • No major geopolitical incidents or developments reported.
  • No significant corporate earnings, M&A, or regulatory announcements.
  • Market trading likely to remain range-bound absent new information.
  • Traders have limited fresh data to reprice risk this hour.

Latest Articles

Coherent Begins Customer Sampling of 300mm High Thermal Conductivity Silicon Carbide Substrates for AI Infrastructure

Coherent Begins Customer Sampling of 300mm High Thermal Conductivity Silicon Carbide Substrates for AI Infrastructure

Coherent Corp. has initiated customer sampling of its newly developed 300mm high thermal conductivity silicon carbide (SiC) substrates aimed at enhancing thermal management for AI and high-performance computing systems. This advancement supports the increasing demands for effective heat removal in high-power density AI processors and marks progress…

TON Strategy Company Appoints Oscar Suarez to Board of Directors and Names Him Audit Committee Chair

TON Strategy Company Appoints Oscar Suarez to Board of Directors and Names Him Audit Committee Chair

TON Strategy Company, a Nasdaq-listed digital asset treasury firm focused on supporting the TON ecosystem, has appointed Oscar Suarez to its Board of Directors and named him Chair of its Audit Committee. Suarez brings over 40 years of accounting, tax, and financial governance experience from notable firms such as KPMG and Ernst & Young, enhancing t…

Corn Futures Tick Up Ahead of Pro Farmer Tour, USDA Ratings

Corn Futures Tick Up Ahead of Pro Farmer Tour, USDA Ratings

Corn futures on the Chicago Board of Trade climbed Monday as market participants awaited results from the Pro Farmer field tour and the USDA's weekly crop ratings report. Market attention is divided between domestic weather-related damage concerns and slower-than-last-year harvest progress in Brazil's center-south region.

Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Zentalis Pharmaceuticals has closed an underwritten public offering raising approximately $92.6 million by selling 26.45 million shares at $3.50 each, including full exercise of underwriters' option to purchase additional shares. The proceeds will fund clinical trials, preclinical studies, regulatory filings, manufacturing, companion diagnostic dev…

Duos Technologies Reports Second Quarter 2026 Results

Duos Technologies Reports Second Quarter 2026 Results

Duos Technologies Group, Inc. announced strong Q2 2026 financial results, with revenues increasing nearly 30% year-over-year driven by a surge in AI and data center deployments. The company secured over $100 million in new capital through multiple transactions, including a direct investment and proceeds from the sale of an asset stake. Duos reaffir…

Funding Growth From Production: Mako Mining's Expansion Trade Setup

Funding Growth From Production: Mako Mining's Expansion Trade Setup

Mako Mining ($MAKO) is trading just under $10 with a market cap near $863M. Technical momentum is constructive and the company’s San Albino focus positions it to convert operating cash flow into additional projects. This trade favors a directional long with defined entry, stop and target tied to operational and news catalysts over the next 180 trad…

FDA eGFR Readout Backs a Speculative Long on Vera Therapeutics

FDA eGFR Readout Backs a Speculative Long on Vera Therapeutics

Vera Therapeutics' recent regulatory win and underlying kidney function data create a buyable dip for traders willing to accept biotech execution and commercial risks. Market cap near $2.3B prices in success, but short interest, healthy liquidity and an improving technical setup make a defined-risk long trade attractive over a mid-term horizon.

Cisco After the Drop: Buy the AI-Driven Dip, Not the Fear

Cisco After the Drop: Buy the AI-Driven Dip, Not the Fear

Cisco's recent pullback looks like an overreaction. The company just raised its AI order target to $9 billion and still generates ~$11.8 billion of free cash flow annually while trading at a mid-30s P/E. This trade idea lays out an entry at $112.41 with tight risk control and a $125 target over a mid-term horizon.

Valneva After VALOR: Why the Lyme Royalty Shift Reprices the Stock

Valneva After VALOR: Why the Lyme Royalty Shift Reprices the Stock

Valneva's partnership with Pfizer and the messy VALOR readout shifted the firm's path from a potential commercial blockbuster to a royalty/milestone-oriented business. That change reduces binary clinical risk but also recasts valuation. With a market cap near $676M, recent product sales and a still-meaningful cash cushion, the shares offer an asymm…

WeRide: Tactical Long After a Convincing Q2 - Plan for a Mid-Term Bounce

WeRide: Tactical Long After a Convincing Q2 - Plan for a Mid-Term Bounce

WeRide's latest quarter surprised the market and reset expectations for commercialization pace. We like a tactical long here: the company is showing improving revenue and better-than-feared unit economics, while market sentiment remains fragile. The trade is sized for a mid-term rebound and uses tight risk controls to respect headline risk in auton…